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Aditya Kotha and Faye Prichard, MA
VCU Honors College

Abstract

Methods

Results

Oncologic diagnosticians are physicians who specialize in interpreting diagnostic exams
to diagnose cancer. Software companies have been developing artificial intelligence [AI]
systems to interpret these exams. These AI systems may affect the traditional role of
diagnosticians if they were to be implemented in the clinical setting. Therefore, I set out to
answer the research question: How will AI and machine learning systems impact the
roles of oncologic diagnosticians in diagnosing cancer and in the patient-physician
relationship? By analyzing surveys and studies, I examined the attitudes of oncologic
diagnosticians and cancer patients toward implementing AI systems in healthcare.
Furthermore, I compared the diagnosing accuracies of AI systems and oncologic
diagnosticians to uncover which screening entity is superior. I also evaluated specific
diagnostic workflows to explore the practical implementations of AI systems in oncology. I
investigated AI systems’ potential effects on the oncologic patient-physician relationship.
Moreover, I reviewed the ethics of utilizing AI systems in cancer diagnostics to determine
if AI implementation is practical. I observed positive attitudes amongst oncologic
diagnosticians and patients towards the usage of AI systems, especially if these systems
are to be used as assistance programs for physicians. In terms of screening accuracy
and the impact on patient-physician relationships, surveys showed a lack of consensus.
There are also several ethical implications present, but policies and guidelines can be
implemented to regulate and manage the usage of AI systems as diagnostic tools. In
summary, AI and machine learning systems seem unlikely to replace oncologic
diagnosticians. Instead, studies suggest that these devices will assist physicians to
reduce diagnostic errors and improve accuracy and reliability. The extent to which the
patient-physician relationship is influenced by AI systems seems likely to depend on the
physician and their style of practice.

Systematic Literature Review: The following perspectives in the literature were analyzed
• Attitudes of oncologic diagnosticians and cancer patients on AI in healthcare
• Diagnosing accuracies of AI systems versus diagnosing accuracies of oncologic diagnosticians
• Diagnostic workflows to outline the practical implementations of AI systems in oncology
• AI’s potential effects on the oncologic patient-physician relationship
• Ethics of utilizing AI systems in cancer diagnostics to determine if AI implementation is practical
Statistics: Graphs created in GraphPad Prism. Statistics from McNemar’s test. p<0.1*, p<0.01**,
p<0.001***, p<0.0001****.

What is a practical diagnostic workflow?

Figure 1. Opinions of Oncologic Diagnosticians and Patients on AI

Summary Figure

Oncologic diagnosticians (left) have a favorable and optimistic attitude towards the integration
and usage of AI in diagnostic oncology. Oncologic patients (right) mostly have a positive attitude
towards integrating AI into diagnostic oncology as assistance programs for diagnosticians.

Current Diagnostic Model
•
•
•

•
•

Typically, two diagnosticians
interpret the cancer screening
exam
If they agree on the diagnosis,
the diagnosis is established
If they disagree on the diagnosis,
another diagnostician interprets
the cancer screening exam and
becomes the deciding factor
AI has the capability to interpret
and evaluate cancer diagnostic
and screening exams
AI can potentially be integrated
into this diagnostic model

Statement of Problem
• Diagnostic errors are an established problem in cancer screening.
• The burden that new cancer cases and deaths place on hospitals is directly related to the
resources required to diagnose cancer.
• While AI will not reduce new cancer cases, the number of cancer deaths can be reduced with
increased screening and improved turnaround times of results, which may be improved by AI.

Figure 3. Proposed
Diagnostic Workflows
Proportional agreement score
measures the percentage of
cases where all screening
entities agree on the
diagnosis. In this figure,
screening entities include
radiologists and AI system
Red Dot. Radiologists had
improved proportional
agreement score when aided
by AI, which indicates there
was more consensus on
diagnoses when the AI was
present in the diagnostic
workflow.
• AI may introduce bias and
influence diagnosticians

Results
What are the beliefs and attitudes?

Conclusions & Future Directions
Conclusions:

Who is more accurate?

Figure 2. Diagnostic Accuracy of AI versus Diagnosticians
AI system ResNet50 CNN was compared with dermatologists (left) when analyzing 134 unique
skin lesions of known outcomes for melanoma. “Sensitivity” = correctly diagnosing melanomapositive samples; “Specificity” = correctly diagnosing melanoma-negative samples. ResNet50
CNN had superior mean sensitivity and specificity rates compared to the dermatologists. AI
system Red Dot was compared with radiologists (right) when analyzing 400 chest x-rays (CXRs).
Red Dot had similar mean sensitivity and specificity rates compared to the radiologists.
• There is a lack of consensus in the literature on whether AI systems or oncologic
diagnosticians are superior because results vary with medical specialty.
• AI systems are either comparable or superior to oncologic diagnosticians depending on
specialty → AI does not seem to be less accurate than oncologic diagnosticians

• Oncologic diagnosticians and cancer patients have favorable and optimistic beliefs and
attitudes towards the integration and usage of AI systems in diagnostic oncology. Cancer
patients express positivity towards AI being used as assistance programs, but they express
negativity towards AI being used as stand-alone diagnostic systems. (Fig. 1)
• AI will influence the patient-physician relationship, but the extent of influence depends on the
amount of reliance the physician places on it and the tasks it is assigned to perform. (Fig. 1)
• The accuracy rates of AI and oncologic diagnosticians seem to fluctuate depending on
specialty. In dermatology, AI was superior in the study shown here. In radiology, AI was
comparable to radiologists. However, it appears that AI is not less accurate than oncologic
diagnosticians. (Fig. 2)
• There are multiple AI systems, and they can vary in performance. An ethical concern is present
because there needs to be regulated standardization of AI systems that will be integrated into
cancer diagnostics. (Fig. 2)
• Oncologic diagnosticians are more in agreement with each other regarding diagnoses when
they are aided by an AI system. One should consider if AI is biasing diagnosticians’ decision
making. (Fig. 3)
These findings support that AI is unlikely to replace oncologic diagnosticians because AI will likely
assist physicians to reduce diagnostic errors. The extent to which the oncologic patient-physician
relationship is influenced is dependent upon how diagnosticians use the AI system.

Future directions:
•
•

The studies analyzed here to assess the usage of AI systems as oncologic diagnostic tools
were performed on a small scale with small sample sizes.
Future studies and experiments should be performed on a large scale with large sample sizes
to understand AI’s effects in cancer diagnostics.
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